Aims and background: Oral submucous fibrosis (OSMF) is a potentially malignant condition of oral cavity. Optimal dosage of local injection of corticosteroids with hyaluronidase is an effective treatment. Case description: A 34 years’ old male, diabetic patient reported with reduced mouth opening. He had a tobacco chewing habit. He was thoroughly examined and diagnosed with OSMF. Due to diabetes, he was advised only hyaluronidase injection. After 4 sessions of intralesional injection, he started developing facial edema after every session that subsided within 48-72 hours. Conclusion: The present report is to discuss a complication of intralesional hyaluronidase therapy. Clinical significance: Hyaluronidase can be administered without corticosteroid in OSMF patients with diabetes keeping in mind the adverse reactions that could happen and how to manage them when encountered.
No takes yet. Share an insight, caveat, or question.
Surajit Bose (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: